How should I manage a patient with left peri‑umbilical pain, normal abdominal exam and imaging, normal inflammatory markers and fecal calprotectin, mild eosinophilia (8 %) and leukopenia (white blood cell count 3.5 ×10⁹/L), who is sitting in abnormal positions?

Management of Left Peri-Umbilical Pain with Normal Inflammatory Markers and Mild Eosinophilia

This patient does not have inflammatory bowel disease and does not require IBD-directed therapy or further IBD-specific workup given the normal fecal calprotectin, normal inflammatory markers (CRP, ESR), and normal imaging. 1

Interpretation of Current Findings

Normal Inflammatory Markers Rule Out Active IBD

• Fecal calprotectin <150 mg/g reliably excludes active intestinal inflammation in patients with gastrointestinal symptoms, with excellent negative predictive value for ruling out IBD 1, 2, 3, 4
• Normal CRP and ESR further support the absence of significant inflammatory bowel disease 1
• The combination of normal calprotectin with normal serum inflammatory markers has high accuracy (80-100%) for differentiating functional from organic gastrointestinal disorders 3, 5

Mild Eosinophilia and Leukopenia Considerations

• Eosinophilia at 8% with WBC 3.5 × 10⁹/L is mild and nonspecific for gastrointestinal pathology 6
• This finding does not indicate eosinophilic gastrointestinal disease requiring further invasive workup in the absence of other supporting features 6
• The leukopenia is mild and may be incidental, but warrants monitoring 6

Behavioral Observations

• Abnormal sitting positions during pain episodes suggest a functional pain disorder rather than organic pathology 1
• This behavioral pattern, combined with normal objective testing, strongly supports a functional diagnosis 1

Recommended Management Approach

Immediate Actions

• Do not pursue endoscopic evaluation given the normal fecal calprotectin and inflammatory markers 1
• Do not initiate empiric IBD treatment as there is no evidence of intestinal inflammation 1
• Rule out extraintestinal infections (urinary tract infection, respiratory infection) that could explain the mild leukopenia 6

Diagnostic Considerations

• Consider functional abdominal pain disorder or irritable bowel syndrome as the most likely diagnosis given normal inflammatory workup and behavioral features 1, 2
• Evaluate for other functional gastrointestinal disorders including functional dyspepsia if upper abdominal symptoms are present 1
• Screen for psychological comorbidities (anxiety, depression, history of trauma) that commonly coexist with functional pain disorders 1

Follow-Up Strategy

• Repeat complete blood count in 4-6 weeks to monitor the mild leukopenia and eosinophilia 6
• If symptoms persist or worsen despite functional disorder management, consider repeat fecal calprotectin in 3-6 months 1
• Only pursue colonoscopy if new alarm features develop (rectal bleeding, unintentional weight loss, anemia, elevated inflammatory markers on repeat testing) 1

Treatment Approach for Functional Pain

• Provide reassurance that serious organic disease has been excluded 1
• Initiate dietary modifications (consider low FODMAP diet trial) 1
• Consider neuromodulators (tricyclic antidepressants or SSRIs) for pain management if symptoms are moderate to severe 1
• Address psychological factors through cognitive behavioral therapy or gut-directed hypnotherapy if available 1

Key Pitfalls to Avoid

• Do not repeat MRI enterography as Crohn's disease has been effectively ruled out with normal calprotectin and imaging 1, 2
• Do not attribute symptoms to the mild eosinophilia without additional supporting evidence of eosinophilic gastrointestinal disease 6
• Avoid unnecessary endoscopy which adds cost and risk without changing management when inflammatory markers are normal 1
• Do not dismiss the patient's pain despite normal testing; functional disorders cause real suffering and require active management 1